https://www.marketwatch.com/story/winnebago-posts-higher-3q-sales-earnings-on-strong-pricing-demand-271655896812?mod=mw_quote_news
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%